Rheumatology Board Review 2026

Register Today

August 20 - 22, 2026
Mission Bay Conference Center • San Francisco, CA
Course# MDM27F01 - Department: Medicine

Overview

The Rheumatology Board Review and Clinical Update course has been offered by UCSF since 1992 and will be presented as a hybrid conference - in person and virtually this year. Join us for three days of a live and live-streamed interactive conference which will include talks on major clinical topics in Rheumatology to assist physicians preparing for the American Board of Internal Medicine (ABIM) Subspecialty Examination in Rheumatology. The course will provide up to date information for practicing clinicians seeking to improve their care for rheumatology patients. An additional series of prerecorded lectures and practice questions are also available to participants.

Target Audience
Trainees preparing for their initial board exam — as well as rheumatologists who are candidates for ABIM recertification — are the target audience. Diagnosing and managing complex and unusual clinical problems will be emphasized; an overview of significant advances related to clinical rheumatology will also be included.

Onsite and Remote Learning Options:
The course will be offered as a live conference. Registrants have the option to attend in person or to tune in remotely via zoom live stream during programming hours (Pacific Time). Login instructions along with the digital syllabus will be shared with attendees before the meeting. Included in your registration fee is access to the course recordings on demand after the conference and through the 2026 Board Exams. You must tune in to the live conference (in person or remotely) to claim CME.

Objectives

An attendee completing this course should be able to:

• Apply current, evidence-based standards of care to rheumatic diseases (including rheumatoid arthritis, systemic lupus erythematosus, scleroderma, other systemic, autoimmune diseases, autoinflammatory diseases, spondyloarthritis, osteoarthritis, osteoporosis, crystalline arthritis, and soft tissue musculoskeletal pain syndromes);
• Improve diagnostic accuracy by application of best available recent data and expert guidance.
• Refine, optimize, and monitor rheumatic disease treatments based on new knowledge of efficacy and safety.
• Adopt newly approved treatments appropriately based on the latest medical evidence.
• Refine approach to pain in rheumatic diseases.
• Increase utilization of self-assessment.

Accreditation

In support of improving patient care, the University of California, San Francisco is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Registration Fees

Early Bird Discount

Early Bird* Before 4/30/2026
$935 Physicians
$835 Advanced Practice Professionals/Nurses
$500 Residents/Fellows
$1,200 Industry Representatives

*Early Bird Discount - Learners must enter EB26 during the registration process to receive the early bird rate.

Regular Fee After 4/30/2026
$985 Physicians
$885 Advanced Practice Professionals/Nurses
$550 Residents/Fellows
$1,200 Industry Representatives

On Site Fee 
$1,035 Physicians
$935 Advanced Practice Professionals/Nurses
$600 Residents/Fellows
$1,200 Industry Representatives

Cancellation Policy

Cancellations received in writing at least 30 days before the conference start date will receive a refund of registration fees minus a [10%] administrative fee. Requests received between 14 and 30 days before the start date will receive a 50% refund. No refunds will be issued within 14 days of the start date. Please send cancellation requests through our Refund Request form.